Ripple Science

Presenter: 

Nestor Lopez-Duran, Founder
Thursday, 17 November 2016 - 5:45pm

Ripple is a HIPAA-compliant web-based tool that facilitates the recruitment and management of research participants for clinical studies.

Research participant under-enrollment is an endemic problem in the life sciences, with over 70% of clinical trials not meeting their recruitment targets.  In fact, participant under-enrollment is the #1 reason why clinical trials fail. Our solution is Ripple, a HIPAA-compliant web-based tool that facilitates the recruitment and management of research participants.  Ripple provides teams with new marketing skills via an innovative campaign creation and management tool, more time via extensive marketing automation tools, and better insight into their performance through smart regional analytics.  Ripple accelerates the entire research lifecycle by increasing the recruitment and retention of research participants.

Dr. Nestor Lopez-Duran is an Associate Professor of Clinical Psychology at the University of Michigan. He conducts clinical translational research on the development of mood disorders in children and adolescents.  He is also an entrepreneur and the co-founder of Ripple, a HIPAA-compliant web-based that facilitates the recruitment and management of research participants for clinical studies. Under his direction, Ripple evolved from a simple idea to a comprehensive cloud utility that transformed the process of research participant recruitment. In his spare time, Dr. Lopez-Duran is an avid sailor who plans to one day circumnavigate the globe.

Update - Year 1: 

Ripple is a web-based software that facilitates the recruitment and management of participants for clinical and translational studies. 2017 has been a defining year for Ripple Science as we achieved multiple major milestones. First, and most importantly, we launched our first product commercially in January. We also hired our first full-time employee and now have 4 employees and the two co-founders working for the company. We raised a first seed round of funding with the participation of Invest Detroit (First Capital Fund), Invest Michigan, and the Monroe Brown fund. Finally, since the launch, we have 28 paying clinical research laboratories at 24 Universities in the USA and the UK using our platform to manage over 20,000 clinical participants. In 2018, we plan to expand into industry clinical trials and begin selling enterprise-level licenses to large Universities and Academic Medical Centers.